Advertisement

Adolescent and Young Adult Bone Health

  • Noor Alhamamy
  • Neil Gittoes
  • Nicola Crabtree
  • Zaki Hassan-SmithEmail author
Chapter
Part of the In Clinical Practice book series (ICP)

Abstract

Adolescents and young adults (AYA) with chronic rheumatic musculoskeletal disease (RMD) have multiple potential risk factors for compromised bone health. The effect of the active inflammatory disease state on bone resorption, malnutrition, reduced physical activity, delayed puberty, vitamin D deficiency and use of glucocorticoid therapy can all result in impaired bone accrual. The impact of chronic RMD on bone density can extend into adulthood, and coupled with the inevitable bone loss during ageing, may lead to increased fragility fractures throughout life. Although many tools can be used to determine bone health, the most useful and widely used technique by far is dual-energy X-ray absorptiometry (DXA). Low bone mineral density (BMD) can be asymptomatic; hence AYAs with chronic RMD may benefit from routine bone health screening. Specific measures include the use of vitamin D and calcium supplements, steroid-sparing medications and the promotion of weight-bearing exercise. This chapter addresses common risk factors for adverse bone health in AYAs with chronic rheumatic diseases and explores the broad approach to prevention and management of bone fragility.

Keywords

Bone mineral density (BMD) Osteoporosis Rheumatic musculoskeletal disease Adolescents Young adults AYA Dual energy X-ray absorptiometry (DXA) Glucocorticoids Bisphosphonates Calcium Vitamin D 

References

  1. 1.
    Matkovic V, Heaney RP. Calcium balance during human growth: evidence for threshold behavior. Am J Clin Nutr. 1992;55:992–6.CrossRefGoogle Scholar
  2. 2.
    Roth J, Bechtold S, Borte G, et al. Osteoporosis in juvenile idiopathic arthritis- a practical approach to diagnosis and therapy. Eur J Pediatr. 2007;166:775–84.  https://doi.org/10.1007/s00431-007-0484-1.CrossRefPubMedGoogle Scholar
  3. 3.
    Bishop N, Arundel P, Clark E, et al. Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2013 pediatric official positions. J Clin Densitom. 2014;17:275–80.  https://doi.org/10.1016/j.jocd.2014.01.004.CrossRefPubMedGoogle Scholar
  4. 4.
    Javaid MK, Cooper C. Prenatal and childhood influences on osteoporosis. Best Pract Res Clin Endocrinol Metab. 2002;16:349–67.  https://doi.org/10.1053/beem.2002.0199.CrossRefPubMedGoogle Scholar
  5. 5.
    Levine MA. Assessing bone health in children and adolescents. Indian J Endocrinol Metab. 2012;16:S205–12.  https://doi.org/10.4103/2230-8210.104040.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Rousseau-Nepton I, Lang B, Rodd C. Long-term bone health in glucocorticoid-treated children with rheumatic diseases. Curr Rheumatol Rep. 2013;15:315.  https://doi.org/10.1007/s11926-012-0315-x.CrossRefPubMedGoogle Scholar
  7. 7.
    Mitchell JA, Cousminer DL, Zemel BS, et al. Genetics of pediatric bone strength. Bonekey Rep. 2016;5:823.  https://doi.org/10.1038/bonekey.2016.50.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Kambas A, Leontsini D, Avloniti A, et al. Physical activity may be a potent regulator of bone turnover biomarkers in healthy girls during preadolescence. J Bone Miner Metab. 2017;35:598–607.  https://doi.org/10.1007/s00774-016-0794-3.CrossRefPubMedGoogle Scholar
  9. 9.
    Davies JH, Evans BAJ, Gregory JW. Bone mass acquisition in healthy children. Arch Dis Child. 2005;90:373–8.  https://doi.org/10.1136/adc.2004.053553.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Lewiecki EM, Borges JLC. Bone density testing in clinical practice. Arq Bras Endocrinol Metabol. 2006;50:586–95.  https://doi.org/10.1590/S0004-27302006000400004.CrossRefPubMedGoogle Scholar
  11. 11.
    Gordon C, Leonard M, Zemel B. 2013 pediatric position development conference: executive summary and reflections. J Clin Densitom. 2014;17:219–24.  https://doi.org/10.1016/j.jocd.2014.01.007.CrossRefPubMedGoogle Scholar
  12. 12.
    Rauch F, Schoenau E. Changes in bone density during childhood and adolescence: an approach based on bone’s biological organization. J Bone Miner Res. 2001;16:597–604.  https://doi.org/10.1359/jbmr.2001.16.4.597.CrossRefPubMedGoogle Scholar
  13. 13.
    Schoenau E, Saggese G, Peter F, et al. From bone biology to bone analysis. Horm Res. 2004;61:257–69.  https://doi.org/10.1159/000076635.CrossRefPubMedGoogle Scholar
  14. 14.
    Coulson EJ, Hanson HJM, Foster HE. What does an adult rheumatologist need to know about juvenile idiopathic arthritis? Rheumatology (Oxford). 2014;53:2155–66.  https://doi.org/10.1093/rheumatology/keu257.CrossRefGoogle Scholar
  15. 15.
    Golden NH, Abrams SA, Committee on Nutrition. Optimizing bone health in children and adolescents. Pediatrics. 2014;134:e1229–43.  https://doi.org/10.1542/peds.2014-2173.CrossRefPubMedGoogle Scholar
  16. 16.
    Cimaz R, Ward L. In: Petty RE, Laxer RM, Lindsley CB, Wedderburn L, editors. Textbook of pediatric rheumatology. 7th ed. Elsevier Health Sciences; 2016. p. 693–705.Google Scholar
  17. 17.
    Shiff NJ, Brant R, Guzman J, et al. Glucocorticoid-related changes in body mass index among children and adolescents with rheumatic diseases. Arthritis Care Res (Hoboken). 2013;65:113–21.  https://doi.org/10.1002/acr.21785.CrossRefGoogle Scholar
  18. 18.
    Huber AM, Gaboury I, Cabral DA, et al. Prevalent vertebral fractures among children initiating glucocorticoid therapy for the treatment of rheumatic disorders. Arthritis Care Res (Hoboken). 2010;62:516–26.  https://doi.org/10.1002/acr.20171.CrossRefGoogle Scholar
  19. 19.
    Rodd C, Lang B, Ramsay T, et al. Incident vertebral fractures among children with rheumatic disorders 12 months after glucocorticoid initiation: a national observational study. Arthritis Care Res (Hoboken). 2012;64:122–31.  https://doi.org/10.1002/acr.20589.CrossRefGoogle Scholar
  20. 20.
    Thornton J, Pye SR, O’Neill TW, et al. Bone health in adult men and women with a history of juvenile idiopathic arthritis. J Rheumatol. 2011;38:1689–93.  https://doi.org/10.3899/jrheum.101232.CrossRefPubMedGoogle Scholar
  21. 21.
    van Staa TP, Leufkens HG, Abenhaim L, et al. Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford). 2000;39:1383–9.CrossRefGoogle Scholar
  22. 22.
    De Vries F, Bracke M, Leufkens HGM, et al. Fracture risk with intermittent high-dose oral glucocorticoid therapy. Arthritis Rheum. 2007;56:208–14.  https://doi.org/10.1002/art.22294.CrossRefPubMedGoogle Scholar
  23. 23.
    Rüegsegger P, Medici TC, Anliker M. Corticosteroid-induced bone loss. A longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography. Eur J Clin Pharmacol. 1983;25:615–20.  https://doi.org/10.1007/BF00542348.CrossRefPubMedGoogle Scholar
  24. 24.
    Devogelaer J-P. Glucocorticoid-induced osteoporosis: mechanisms and therapeutic approach. Rheum Dis Clin. 2017;32:733–57.  https://doi.org/10.1016/j.rdc.2006.09.001.CrossRefGoogle Scholar
  25. 25.
    Layne JE, Nelson ME. The effects of progressive resistance training on bone density: a review. Med Sci Sports Exerc. 1999;31:25–30.CrossRefGoogle Scholar
  26. 26.
    Nichols DL, Sanborn CF, Love AM. Resistance training and bone mineral density in adolescent females. J Pediatr. 2017;139:494–500.  https://doi.org/10.1067/mpd.2001.116698.CrossRefGoogle Scholar
  27. 27.
    Boreham CAG, McKay HA. Physical activity in childhood and bone health. Br J Sports Med. 2011;45:877–9.CrossRefGoogle Scholar
  28. 28.
    Koedijk JB, van Rijswijk J, Oranje WA, et al. Sedentary behaviour and bone health in children, adolescents and young adults: a systematic review. Osteoporos Int. 2017;28:2507–19.  https://doi.org/10.1007/s00198-017-4076-2.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Hassan-Smith ZK, Hewison M, Gittoes NJ. Effect of Vitamin D deficiency in developed countries. Br Med Bull. 2017;122.  https://doi.org/10.1093/bmb/ldx005.CrossRefGoogle Scholar
  30. 30.
    Aspray TJ, Bowring C, Fraser W, et al. National osteoporosis society vitamin D guideline summary. Age Ageing. 2014;43:592–5.  https://doi.org/10.1093/ageing/afu093.CrossRefPubMedGoogle Scholar
  31. 31.
    Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911–30.  https://doi.org/10.1210/jc.2011-0385.CrossRefPubMedGoogle Scholar
  32. 32.
    Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96:53–8.  https://doi.org/10.1210/jc.2010-2704.CrossRefPubMedGoogle Scholar
  33. 33.
    Vojinovic J, Cimaz R. Vitamin D—update for the pediatric rheumatologists. Pediatr Rheumatol Online J. 2015;13:18.  https://doi.org/10.1186/s12969-015-0017-9.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Sioen I, Michels N, Polfliet C, et al. The influence of dairy consumption, sedentary behaviour and physical activity on bone mass in Flemish children: a cross-sectional study. BMC Public Health. 2015;15:717.  https://doi.org/10.1186/s12889-015-2077-7.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Vogel KA, Martin BR, McCabe LD, et al. The effect of dairy intake on bone mass and body composition in early pubertal girls and boys: a randomized controlled trial. Am J Clin Nutr. 2017;105:1214–29.  https://doi.org/10.3945/ajcn.116.140418.CrossRefPubMedGoogle Scholar
  36. 36.
    Willems HME, van den Heuvel EGHM, Schoemaker RJW, et al. Diet and exercise: a match made in bone. Curr Osteoporos Rep. 2017;15:555–63.  https://doi.org/10.1007/s11914-017-0406-8.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Dwan K, Phillipi CA, Steiner RD, Basel D. Bisphosphonate therapy for osteogenesis imperfecta. Cochrane Database Syst Rev. 2016.  https://doi.org/10.1002/14651858.CD005088.pub4.
  38. 38.
    Rooney M, Bishop N, Pilkington C, Beresford M, Clinch J, Satyapal R, Foster H, Gardner-Medwin J, McDonagh J, Wyatt S, on behalf of BSPAR. Prevention and treatment of steroid induced osteopenia in children and adolescents with rheumatic diseases: the pops study. PRES. 2016;15(Suppl 1):37.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Noor Alhamamy
    • 1
    • 2
  • Neil Gittoes
    • 1
    • 2
  • Nicola Crabtree
    • 3
  • Zaki Hassan-Smith
    • 1
    • 2
    • 4
    Email author
  1. 1.Department of EndocrinologyQueen Elizabeth Hospital BirminghamBirminghamUK
  2. 2.Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health PartnersBirminghamUK
  3. 3.Department of Nuclear MedicineBirmingham Children’s HospitalBirminghamUK
  4. 4.Faculty of Health and Life SciencesCoventry UniversityCoventryUK

Personalised recommendations